Dai Ishikawa

17PUBLICATIONS
25CO-AUTHORS
AllergyIntensive careFood properties (incl. characteristics and health benefits)Innate immunityMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 22, 2026
Recurrent local and systemic hypersensitivity reactions after switching back from subcutaneous to intravenous vedolizumab in ulcerative colitis: a case presentation.

|Feb 27, 2026
Perceived Impact of a Junior-Senior Inpatient Team Model on Clinical Workflow, Supervision, and Workload in a Tertiary Gastroenterology Department: A Mixed-Methods Study.

Akira Uchiyama, Hiroo Fukada, Tsutomu Takeda

|Aug 28, 2025
Hydrogen Gas Inhalation Improved Intestinal Microbiota in Ulcerative Colitis: A Randomised Double-Blind Placebo-Controlled Trial.

Takafumi Maruyama, Dai Ishikawa, Rina Kurokawa

|Jul 01, 2025
Fecal microbiota transplantation for immune regulation: improving ulcerative colitis and enhancing cancer immunotherapy.

Xiaochen Zhang, Dai Ishikawa, Akihito Nagahara

|Apr 01, 2025
Patient-donor similarity and donor-derived species contribute to the outcome of fecal microbiota transplantation for ulcerative colitis.

Dai Ishikawa, Hikaru Watanabe, Kei Nomura

|Sep 28, 2024
Comparison of the Effectiveness of Vedolizumab and Ustekinumab in Patients with Ulcerative Colitis: A Real-World Retrospective Study.

Kei Nomura, Tomoyoshi Shibuya, Rina Odakura

Pageof 3

Frequent Collaborators

12 joint publications

Tomoyoshi Shibuya

10 joint publications

Kei Nomura

10 joint publications

Akihito Nagahara

5 joint publications

Mariko Hojo